Cryo Cell International (CCEL) Share-based Compensation (2016 - 2026)
Cryo Cell International's Share-based Compensation history spans 17 years, with the latest figure at $158549.0 for Q1 2026.
- Quarterly results put Share-based Compensation at $158549.0 for Q1 2026, down 46.62% from a year ago — trailing twelve months through Feb 2026 was $278131.0 (down 63.9% YoY), and the annual figure for FY2025 was $417000.0, down 46.61%.
- Share-based Compensation for Q1 2026 was $158549.0 at Cryo Cell International, up from $42802.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $313000.0 in Q1 2023 to a low of $31896.0 in Q1 2022.
- The 5-year median for Share-based Compensation is $157000.0 (2023), against an average of $154957.9.
- The sharpest move saw Share-based Compensation soared 881.31% in 2023, then tumbled 77.53% in 2025.
- Year by year, Share-based Compensation stood at $150904.0 in 2022, then grew by 16.17% to $175310.0 in 2023, then fell by 14.69% to $149565.0 in 2024, then tumbled by 71.38% to $42802.0 in 2025, then surged by 270.42% to $158549.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods came in at $158549.0, $42802.0, and $36780.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.